register

News & Trends - Pharmaceuticals

Experts urge action to cut diagnostic delays in deadliest cancer affecting young adults

Health Industry Hub | May 30, 2024 |

Early-onset colorectal cancer (bowel cancer), diagnosed in individuals younger than 50, is on the rise, with critical warning signs often overlooked, leading to delays in diagnosis.

An international systematic review and meta-analysis involving nearly 25 million patients from 81 studies identified the most common symptoms of early-onset bowel cancer. These include blood in the stool (hematochezia), abdominal pain, altered bowel habits, and unexplained weight loss.

“In Australia, the risk of diagnosis with bowel cancer before age 40 has more than doubled since 2000, and knowing the symptoms is only part of the solution,” said Bowel Cancer Australia Medical Director, A/Prof Graham Newstead AM.

The study found that blood in the stool and abdominal pain were significantly associated with early-onset bowel cancer, with likelihoods increased by 5 to 54-fold and 1.3 to 6-fold, respectively.

“This latest study sends a clear message to GPs and younger people of the need to have a high suspicion of red flag signs and symptoms and to work together to ensure prompt access to colonoscopy to rule out early-onset bowel cancer as an underlying cause or to improve outcomes,” added A/Prof Newstead.

The researchers recommend that GPs implement a follow-up visit within 30 to 60 days for younger patients to confirm the initial diagnosis, check if the symptoms persist, or refer for a colonoscopy to exclude early-onset bowel cancer.

“Regardless of age, blood in the stool must be investigated for possible underlying bowel cancer,” A/Prof Newstead emphasised.

The analysis also highlighted that diagnostic delays are common, with the time from symptom onset to bowel cancer diagnosis ranging from 1.8 to 13.7 months, averaging 6.4 months. These delays are up to 40% longer for younger patients compared to older individuals, potentially leading to more late-stage diagnoses and higher mortality rates.

Supporting recent Australian research, the systematic review and meta-analysis revealed that younger people see multiple doctors over three months to five years before receiving a diagnosis. They make ten or more GP visits, with diagnostic times up to 60% longer than older patients, often resulting in later-stage diagnoses.

Early-onset bowel cancer is increasingly prevalent both in Australia and globally and is the deadliest cancer for individuals aged 25-44.

In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - MedTech & Diagnostics

APAC medtech company scores TGA approval in heart disease

APAC medtech company scores TGA approval in heart disease

Health Industry Hub | October 4, 2024 |

MedTech & Diagnostics News: An Asia Pacific medtech company has announced that its flagship drug-eluting stent (DES) has received regulatory […]

More


News & Trends - MedTech & Diagnostics

New state-based pilot to back home-grown medtech innovation

New state-based pilot to back home-grown medtech innovation

Health Industry Hub | October 4, 2024 |

MedTech & Diagnostics: In a bid to enhance opportunities for local medtech manufacturers to sell to health services, a connected […]

More


News & Trends - Pharmaceuticals

Ferring unveils first real-world evidence for faecal calprotectin approach in ulcerative colitis

Ferring unveils first real-world evidence for faecal calprotectin approach in ulcerative colitis

Health Industry Hub | October 4, 2024 |

Pharma News: Ferring Pharmaceuticals has announced results from a new study, which provides the first real-world evidence supporting the efficacy […]

More


News & Trends - Pharmaceuticals

Bayer partners with RACGP, calls for MBS reforms to boost access to long-acting contraceptives

Bayer partners with RACGP, calls for MBS reforms to boost access to long-acting contraceptives

Health Industry Hub | October 4, 2024 |

Pharma News: Australian women are calling for more accurate information about their contraceptive options, with 70% feeling inadequately educated about […]

More


This content is copyright protected. Please subscribe to gain access.